Regorafenib Alone or in Combined With Transcatheter Arterial ChEmoembolization in Treatment of Advanced Hepatocellular Carcinoma After First Line Targeted Therapy
Clinical trial NCT05811481 · UNKNOWN
Trial details
- NCT number
- NCT05811481
- Sponsor
- WenBo Guo
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2022-12-27
- Primary completion
- 2024-12-27
- Enrollment
- 192
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.